The microRNA-29 Family Dictates the Balance Between Homeostatic and Pathological Glucose Handling in Diabetes and Obesity

The microRNA-29 (miR-29) family is among the most abundantly expressed microRNA in the pancreas and liver. Here, we investigated the function of miR-29 in glucose regulation using miR-29a/b-1 (miR-29a)-deficient mice and newly generated miR-29b-2/c (miR-29c)-deficient mice. We observed multiple independent functions of the miR-29 family, which can be segregated into a hierarchical physiologic regulation of glucose handling. miR-29a, and not miR-29c, was observed to be a positive regulator of insulin secretion in vivo, with dysregulation of the exocytotic machinery sensitizing β-cells to overt diabetes after unfolded protein stress. By contrast, in the liver both miR-29a and miR-29c were important negative regulators of insulin signaling via phosphatidylinositol 3-kinase regulation. Global or hepatic insufficiency of miR-29 potently inhibited obesity and prevented the onset of diet-induced insulin resistance. These results demonstrate strong regulatory functions for the miR-29 family in obesity and diabetes, culminating in a hierarchical and dose-dependent effect on premature lethality.

[1]  J. Schneider,et al.  Combinatorial regulation of lipoprotein lipase by microRNAs during mouse adipogenesis , 2014, RNA biology.

[2]  An-fang Cui,et al.  MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis. , 2013, Journal of hepatology.

[3]  Kyle J. Gaulton,et al.  The miRNA Profile of Human Pancreatic Islets and Beta-Cells and Relationship to Type 2 Diabetes Pathogenesis , 2013, PloS one.

[4]  L. Dalgaard,et al.  Syntaxin-1a is a Direct Target of miR-29a in Insulin-producing β-Cells , 2013, Hormone and Metabolic Research.

[5]  J. Nielsen,et al.  MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretion. , 2012, Biochemical and biophysical research communications.

[6]  Aikaterini S. Papadopoulou,et al.  MicroRNA-29 in the adaptive immune system: setting the threshold , 2012, Cellular and Molecular Life Sciences.

[7]  Y. Dor,et al.  Dysregulation of Dicer1 in Beta Cells Impairs Islet Architecture and Glucose Metabolism , 2012, Experimental diabetes research.

[8]  W. Foulkes,et al.  Exploring the endocrine manifestations of DICER1 mutations. , 2012, Trends in molecular medicine.

[9]  G. Rutter,et al.  Overexpression of Monocarboxylate Transporter-1 (Slc16a1) in Mouse Pancreatic β-Cells Leads to Relative Hyperinsulinism During Exercise , 2012, Diabetes.

[10]  P. Meda,et al.  Changes in MicroRNA Expression Contribute to Pancreatic β-Cell Dysfunction in Prediabetic NOD Mice , 2012, Diabetes.

[11]  A. Näär,et al.  MicroRNAs in metabolism and metabolic disorders , 2012, Nature Reviews Molecular Cell Biology.

[12]  Aikaterini S. Papadopoulou,et al.  The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor , 2011, Nature Immunology.

[13]  L. Eliasson,et al.  Beta-Cell Specific Deletion of Dicer1 Leads to Defective Insulin Secretion and Diabetes Mellitus , 2011, PloS one.

[14]  G. Rutter,et al.  miR-29a and miR-29b Contribute to Pancreatic β-Cell-Specific Silencing of Monocarboxylate Transporter 1 (Mct1) , 2011, Molecular and Cellular Biology.

[15]  Y. Dor,et al.  miRNAs control insulin content in pancreatic β‐cells via downregulation of transcriptional repressors , 2011, The EMBO journal.

[16]  A. Pandey,et al.  miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells , 2011, Molecular and Cellular Endocrinology.

[17]  Michael T. McManus,et al.  Analysis of microRNA knockouts in mice. , 2010, Human molecular genetics.

[18]  Michael T. McManus,et al.  Dicer is required for proper liver zonation , 2009, The Journal of pathology.

[19]  L. Dai,et al.  A protocol for islet isolation from mouse pancreas , 2009, Nature Protocols.

[20]  Michael T. McManus,et al.  Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. , 2009, Gastroenterology.

[21]  Aibin He,et al.  Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. , 2007, Molecular endocrinology.

[22]  J. Ellis,et al.  Transgenic mouse overexpressing syntaxin-1A as a diabetes model. , 2005, Diabetes.

[23]  D. Levy,et al.  Disruption of the gamma-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of beta-cells. , 2005, Diabetes.

[24]  C. Wollheim,et al.  Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. , 1999, The Journal of clinical investigation.

[25]  M. Magnuson,et al.  Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.

[26]  M. Davis,et al.  A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. , 1997, Immunity.